These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31528096)

  • 1. Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis.
    Zhu RX; Cheng ASL; Chan HLY; Yang DY; Seto WK
    World J Gastroenterol; 2019 Aug; 25(32):4715-4726. PubMed ID: 31528096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.
    Pok S; Wen V; Shackel N; Alsop A; Pyakurel P; Fahrer A; Farrell GC; Teoh NC
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1545-54. PubMed ID: 23574010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.
    Zhu Z; Lin J; Qu JH; Feitelson MA; Ni CR; Li FM; Zhu MH
    World J Gastroenterol; 2005 Apr; 11(13):1903-9. PubMed ID: 15800978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
    Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
    Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
    Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
    Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma.
    Lu Y; Zhou J; Zhang J; Wang Z; Yu Y; Miao M; Yao Q
    Biomed Pharmacother; 2019 Dec; 120():109532. PubMed ID: 31605953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.
    Zhang X; Zheng Q; Yue X; Yuan Z; Ling J; Yuan Y; Liang Y; Sun A; Liu Y; Li H; Xu K; He F; Wang J; Wu J; Zhao C; Tian C
    J Exp Clin Cancer Res; 2022 Feb; 41(1):79. PubMed ID: 35227287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma.
    Guo Y; Wang J; Li H; Liu W; Chen D; Zhao K; Liang X; Zhang Q; Yang Y; Chen G
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1094-103. PubMed ID: 25684393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

  • 19. Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines
    Hu YT; Li BF; Zhang PJ; Wu D; Li YY; Li ZW; Shen L; Dong B; Gao J; Zhu X
    World J Gastroenterol; 2019 Feb; 25(8):923-940. PubMed ID: 30833799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.